Abstract
Angiogenesis plays a major role in multiple disease processes including cancer, and new agents that modulate angiogenesis are rapidly entering clinical trials. The understanding of the biological mechanisms and downstream effects for many of these agents is poorly understood. It is therefore important that methods evolve to understand how an agent regulates angiogenesis, in order to promote a higher percentage of successful drug candidates. With the emergence of microarray technology for the evaluation of gene expression, researchers have a powerful tool for dissecting the biological mechanisms of angiogenesis. However, huge data sets and complex statistics pose a hurdle for the investigator to obtain useful and meaningful data. To eliminate problems in data analysis, proper design and planning prior to performing a microarray experiment is crucial to making valid conclusions. This review will discuss the critical factors in designing, performing and analysing microarray experiments, and the utility of various models of angiogenesis for microarray analysis.
Original language | English (US) |
---|---|
Pages (from-to) | 545-556 |
Number of pages | 12 |
Journal | Expert opinion on biological therapy |
Volume | 2 |
Issue number | 5 |
DOIs | |
State | Published - Jul 14 2002 |
Keywords
- Angiogenesis
- Gene expression profiling
- Microarray
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
- Clinical Biochemistry